Skip to content Skip to footer
Vivos Announces Collaboration to Support International Expansion

Vivos Announces Collaboration in the Middle East North Africa to Support International Expansion

October 05, 2023 07:30 ET | Source: Vivos Therapeutics, Inc Vivos Executes Distribution Agreement with Established Dubai-based Sleep Testing Company Subject to Regulatory Approvals, Vivos Could See Revenue From This Collaboration in 2024 LITTLETON, Colo., Oct. 05, 2023 (GLOBE NEWSWIRE) --  Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing…

Read More

stock market ga577ac06f 1920

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers

New Relationships Expected to Add Potentially Significant New Revenue Opportunities for Vivos as well as Airway-Focused Expertise and Potential Cost Savings for Vivos-trained Providers October 04, 2023 07:30 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and…

Read More

The New Science of a Lost Art - James Nestor

New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference

Vivos Attracts Wide Group of Experts in Dental and Medical Disciplines With a Shared Vision to Treat the Millions of Patients Suffering with Breathing-Related Sleep Disorders October 02, 2023 07:30 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical…

Read More

Vivos 2023 Q2 Financial Results

Vivos Reports Q2 2023 Financial Results & Provides Operational Update

August 16, 2023 16:05 ET | Source: Vivos Therapeutics, Inc Operating Expenses Decreased 31% Quarter Over Quarter and 25% Year to Date, Reflecting Cost Cutting Initiatives Management to Host Conference Call Today at 6:00 pm ET LITTLETON, Colo., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a medical technology company focused…

Read More

Financial Results

Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call

August 16, 2023 07:30 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with…

Read More

Vivos Conference Call

Vivos to Reschedule Q2 2023 Financial Results Conference Call

August 14, 2023 17:06 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related…

Read More

Blog ED scaled

Does OSA Cause ED? It Doesn’t Have To.

This blog has been medically reviewed by Theresa Vuskovich, DMD.  For many adults around the world, erectile dysfunction (ED) is a significant problem. According to the International Journal of Impotence Research, 322 million men worldwide are expected to suffer from erectile dysfunction by 2025. This condition can develop for various reasons, one of which is obstructive sleep apnea.…

Read More